Christopher Woolley, MD
Interventional Pain Medicine · Reno, NVNPI 1659734986
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (51.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 47.2% of the total. Reporting peaked in 2020 at $9,669 and has fallen 90.4% since, to $930 in 2025.
Across 199 payments — averaging $88.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Medtronic$4K
- Abbott$2K
- Relievant Medsystems, Inc.$1K
- SPR Therapeutics, Inc$357
- Saluda Medical Americas, Inc.$274
- plus $670 from 13 others
What the payments were for
- Grants$9,00051%
- Travel & lodging$2,84616%
- Food & beverage$5,81633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 118 | $8,345 |
| Medtronic(2 entities) | 8 | $4,405 |
| Abbott | 22 | $2,353 |
| Relievant Medsystems, Inc. | 8 | $1,258 |
| SPR Therapeutics, Inc | 8 | $357 |
| Saluda Medical Americas, Inc. | 10 | $274 |
| Nalu Medical, Inc. | 6 | $149 |
| Nevro Corp. | 4 | $135 |
| AbbVie(2 entities) | 4 | $89 |
| Merz North America, Inc. | 2 | $85 |
| Merz Pharmaceuticals, LLC | 1 | $52 |
| Globus Medical | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$5,000
- SYNCHROMED$4,000
- Intracept$2,209
- PROCLAIM$1,870
- SPRINT PNS System$200
- WaveWriter Alpha Prime 16$157
- GENERAL PAIN MANAGEMENT$120
- INTELLIS$111
How this compares
$17,662 in reported general payments places this provider in the 85th percentile of 32 interventional pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 131 | $3,933 |
| Gabapentin | 138 | $1,641 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $1,485 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 57 | $1,305 |
| Tizanidine Hcl | 96 | $1,273 |
| Duloxetine Hcl | 72 | $842 |
| Methocarbamol | 84 | $686 |
| Oxycodone Hcl | 37 | $631 |
| Cyclobenzaprine Hcl | 59 | $563 |
| Celecoxib | 23 | $458 |
| Tramadol Hcl | 20 | $173 |
| Meloxicam | 59 | $169 |
| Ibuprofen | 18 | $106 |
| Oxcarbazepine | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Reno
- Ali NairiziReno$291K
- Steven BermanReno$25K
- Benjamin GillReno$22K
- Adam AntflickLas Vegas$26K
- Stephen GephardtLas Vegas$14K
- Jeremy LipshutzLas Vegas$13K
- Denys GoloshchapovLas Vegas$11K
- Jeffrey KatzNorth Las Vegas$7K
- Edson ErkulvrawatrLas Vegas$6K
- Alafuro OrueneLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.